Scholars Central

Conference abstractPublished 2018

Circulating miRNAs: A cancer screening biomarkers in rectal cancer

Authors: Veronika Vymetalkova, Jana Slyskova, Klara Cervena, Alena Opattova, Pavel Vodicka

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Circulating microRNAs (miRNAs) in the blood represent a new form of biomarkers for disease diagnosis and prognosis. Early detection of rectal cancer (RC) is the main prerequisite for successful treatment and reduction of mortality. In this study, we aimed to evaluate the levels of circulating miRNAs that might serve as markers for RC diagnosis, prognosis and survival. First, miRNA array screening (2,555 miRNA investigated) in 102 paired RC samples (tumor and non-malignant mucosa) was used to select candidate markers. 11 miRNAs expression levels were associated with recurrence free survival after adjuvant therapy. These candidate miRNAs associated with patient’s survival and treatment response were profiled in plasma samples from 100 subjects with RC collected at 2-time intervals and compared to 40 healthy controls. The first sampling was collected at the time of diagnosis, (i.e., active disease) the second sampling was conducted around one year after the diagnosis. Higher expression levels of miRNA-18a/b and miRNA-19a/b was identified to be associated with a shorter overall survival in RC patients. The second aim of this study was to compare next generation sequencing (NGS) technologies that have been optimized specifically miRNAs, with qRT-PCR-based methods for profiling miRNAs in biofluids. Plasma miRNA expression were thus additionally characterized by next generation sequencing in 24 patients over time and validated in 100 subjects with RC collected at 2-time intervals. Higher expression levels of miRNA-122 were identified to be associated with a shorter overall survival in RC patients. We believe that our results provide evidence that circulating miRNAs might be a next-generation biomarker and contribute to cancer screening in non-invasive liquid biopsy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives in Cancer Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Veronika Vymetalkova”
  • BylineArticles whose byline prints “Jana Slyskova”
  • BylineArticles whose byline prints “Klara Cervena”
  • BylineArticles whose byline prints “Alena Opattova”
  • BylineArticles whose byline prints “Pavel Vodicka”